Manufacturer: Lilly, France, for Eli Lilly and Company, Indianapolis, IN
Indication: Stimulation of new bone formation in patients with osteoporosis
Drug Class: Teriparatide is a recombinant human parathyroid hormone (PTH), which is the primary regulator of calcium and phosphate metabolism in bones. It has an identical sequence to the 34N-terminal amino acids (the biologically active region) of [...]

Continue reading " Pharmaceutical-Approval Update: Teriparatide (rDNA Origin) Injection (Forteo®) "

Manufacturer: Eli Lilly and Company, Indianapolis, IN Indication: Attention-deficit hyperactivity disorder (ADHD)
Drug Class: Atomoxetine is classified as a selective norepinephrine reuptake inhibitor.
Uniqueness of Drug: The precise mechanism by which atomoxetine produces its therapeutic effects in ADHD is unknown, but it is thought to be related to selective inhibition of the presynaptic norepinephrine transporter. Atomoxetine is [...]

Continue reading " Pharmaceutical-Approval Update: Atomoxetine Hydrochloride (Strattera™) "

Ezetimibe (Zetia drug)
Manufacturer: Schering Corporation, Kenilworth NJ, for Merck/Schering-Plough Pharmaceuticals, North Wales, PA (joint venture)
Indications: Primary hypercholesterolemia. Eze-timibe can be prescribed in several situations:

Continue reading " Pharmaceutical-Approval Update "

Several obstacles to vaccination have been identified, not the least of which is the uncertainty surrounding the potential threat of a deliberate release of the smallpox virus. The risk of such an exposure is presumed to be low, but the population at risk cannot be estimated should an exposure occur. As a result, the ACIP [...]

Continue reading " Smallpox Vaccine: OBSTACLES TO VACCINATION "

On December 13, 2002, President Bush announced the National Smallpox Immunization Plan (NSIP) to immunize health care workers who might have to respond to patients affected by an outbreak of smallpox. This plan is designed to help local and state authorities in planning and preparedness by providing vaccine to approximately 500,000 individuals. This program is [...]

Continue reading " Smallpox Vaccine "

The efforts of managed care organizations to control health care costs may have spread eastward from California, but innovation in controlling prescription drug spending today is flowing in the opposite direction. In 2000, the state of Maine enacted an aggressive plan, called “Maine Rx,” to force pharmaceutical companies to lower the prices of drugs for [...]

Continue reading " Maine’s Plan to Lower Drug Costs "

Manufacturer: Ortho-McNeil Johnson & Johnson) Indication: To treat multidrug-resistant strains of Streptococcus pneumoniae (MDRSP) in community acquired pneumonia (CAP).
Drug Class: Levofloxacin generic is a fluoroquinolone (a chiral flu-orinated carboxyquinolone).

Continue reading " Pharmaceutical-Approval Update: Levofloxacin Tablets/Injection and Levofloxacin in 5% Dextrose Injection (Levaquin®) "